DRUG THE UNDRUGGABLE Trademark

Trademark Overview

On Monday, January 31, 2022, a trademark application was filed for DRUG THE UNDRUGGABLE with the United States Patent and Trademark Office. The USPTO has given the DRUG THE UNDRUGGABLE trademark a serial number of 79337628. The federal status of this trademark filing is REGISTERED as of Tuesday, August 15, 2023. This trademark is owned by Defence Therapeutics Inc.. The DRUG THE UNDRUGGABLE trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of intracellular enhancers in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals
drug the undruggable

General Information

Serial Number79337628
Word MarkDRUG THE UNDRUGGABLE
Filing DateMonday, January 31, 2022
Status700 - REGISTERED
Status DateTuesday, August 15, 2023
Registration Number7134981
Registration DateTuesday, August 15, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements

Goods and ServicesDrug delivery agents consisting of intracellular enhancers in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDefence Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCA
Party NameDefence Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCA
Party NameDefence Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCA

Trademark Events

Event DateEvent Description
Monday, December 11, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 16, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 16, 2023FINAL DISPOSITION PROCESSED
Wednesday, November 15, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 15, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 15, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 30, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 10, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 14, 2023REFUSAL PROCESSED BY IB
Friday, January 20, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 20, 2023REFUSAL PROCESSED BY MPU
Tuesday, November 15, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 14, 2022NON-FINAL ACTION WRITTEN
Monday, November 14, 2022ASSIGNED TO EXAMINER
Tuesday, April 12, 2022APPLICATION FILING RECEIPT MAILED
Friday, April 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 7, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

undruggable drug delivery facilitate wide pharmaceuticals compounds range enhancers agents consisting intracellular